Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2559
Abstract: The development of therapies to prevent or delay the onset of type 1 diabetes (T1D) remains challenging, and there is a lack of qualified biomarkers to identify individuals at risk of developing T1D or to… read more here.
Keywords: prevention; type diabetes; model; prevention studies ... See more keywords
The use of placebo in schizophrenia relapse prevention studies: scientific or ethical debate?
Sign Up to like & getrecommendations! Published in 2019 at "Acta Psychiatrica Scandinavica"
DOI: 10.1111/acps.13085
Abstract: The placebo-controlled, relapse prevention studies (PCRPS) have recently been recently been singled out as redundant, disproportionately harmful, unnecessary and therefore ethically impermissible (1). The logic of comparison behind PCRPS has also been questioned as they… read more here.
Keywords: relapse; use placebo; relapse prevention; prevention studies ... See more keywords